Cargando…
Receptor-Mediated Redox Imbalance: An Emerging Clinical Avenue against Aggressive Cancers
Cancer cells are more vulnerable to abnormal redox fluctuations due to their imbalanced antioxidant system, where cell surface receptors sense stress and trigger intracellular signal relay. As canonical targets of many targeted therapies, cell receptors sensitize the cells to specific drugs. On the...
Autores principales: | Dai, Xiaofeng, Thompson, Erik W., Ostrikov, Kostya (Ken) |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775490/ https://www.ncbi.nlm.nih.gov/pubmed/36551308 http://dx.doi.org/10.3390/biom12121880 |
Ejemplares similares
-
Lysine Acetylation, Cancer Hallmarks and Emerging Onco-Therapeutic Opportunities
por: Hu, Meilan, et al.
Publicado: (2022) -
Cold Atmospheric Plasma: A Promising Controller of Cancer Cell States
por: Dai, Xiaofeng, et al.
Publicado: (2020) -
WITHDRAWN: ROS-Driven selection pressure on COVID-19
patients with cardiovascular comorbidities
por: Dai, Xiaofeng, et al.
Publicado: (2021) -
Innovative Precision Gene‐Editing Tools in Personalized Cancer Medicine
por: Dai, Xiaofeng, et al.
Publicado: (2020) -
When Onco-Immunotherapy Meets Cold Atmospheric Plasma: Implications on CAR-T Therapies
por: Dai, Xiaofeng, et al.
Publicado: (2022)